[PDF] Top 20 Caracterización de los pacientes con enfermedad por reflujo gastroesofágico.
Has 10000 "Caracterización de los pacientes con enfermedad por reflujo gastroesofágico." found on our website. Below are the top 20 most common "Caracterización de los pacientes con enfermedad por reflujo gastroesofágico.".
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
... In contrast to most bacterial infections, the diagnosis of IFIs is challenging. Delay in diagnosis leads to delayed initia- tion of appropriate antifungal therapy and, hence, increased mortality. In this ... See full document
8
Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole
... of invasive fungal infections in patients with neutropenia and for the treatment of invasive fungal infections in hematopoietic stem cell transplant recipients with ... See full document
240
Pharmacoeconomic evaluation of voriconazole vs liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
... of patients receiving voriconazole and LAmB, the rate of discontinu- ation due to nephrotoxicity, hepatotoxicity or infusion- related reactions, as well as the occurrence of baseline fungal ... See full document
88
Meta analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections
... The primary outcome was the proportion of patients who discontinued antifungal therapy due to adverse events. The secondary outcome of interest was the cumulative incidence of adverse events related to ... See full document
9
Role of isavuconazole in the treatment of invasive fungal infections
... of invasive fungal infections continues to ...treat invasive fungal infections include polyenes, triazoles, and ...with invasive aspergillosis (IA) or mucormycosis. ... See full document
26
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
... comprised patients with haematological malignancy and prolonged neutropenia or those undergoing ...Eligible patients met the criteria for proven or probable IA defined in the key randomised clinical trials ... See full document
6
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
... difficult infections to treat and the cost of therapy adds additional burden to the United States healthcare ...for invasive aspergillo- sis, based on the Infectious Disease Society of America ... See full document
17
Anidulafungin in the treatment of invasive fungal infections
... primary therapy for candidemia and invasive candidiasis in non-neutropenic ...and amphotericin B, as well as caspofungin and ...and amphotericin B ...on safety, ... See full document
28
Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients
... systemic liposomal amphotericin-B or voriconazole was ...started. Patients were then periodically evaluated at the ENT clinic with nasal endoscopy (every 24–48 h) until neutropenia was ... See full document
6
<p>Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis</p>
... 5,177 patients treated with 11 different ...Regarding safety, the two regimens showed acceptable grade 3 or greater hematologic toxicity and heart ... See full document
30
A Study on the Pattern of Fungal Infections and Clinical Profile in Immunocompromised Patients with Special Reference to Characterisation and Molecular Study of Candida Species In A Tertiary Care Hospital
... 64. Intensive Care Med DOI 10.1007/s00134-014-3603-2 Incidence, characteristics and outcome of ICU-acquired candidemia in India Arunaloke Chakrabarti Prashant Sood Shivaprakash M. Rudramurthy Sharon Chen Harsimran Kaur ... See full document
167
MANAGEMENT OF FEBRILE NEURTROPENIA IN ONCOLOGY PRACTICE
... neutropenic patients who are expected to have a total duration of neutropenia >7 days who have persistent or recurrent fever and in whom reassessment does not yield a ...undiagnosed fungal infection was ... See full document
75
Mucormycosis in renal transplant recipients: review of 174 reported cases
... RT patients. We find that the incidence of mucormycosis in RT patients was growing within the past several ...sive therapy, prolonged prophylaxis with antifungals lacking Table 4 Relationship between ... See full document
5
The use of ciprofloxacin and fluconazole in Italian neonatal intensive care units: a nationwide survey
... recommend amphotericin B or, as a reasonable alternative, fluconazole at a dosage of 12 mg/kg daily for 3 ...of therapy (3 administer it for 3 weeks, 1 for 28 days, and 1 for 15–21 ... See full document
14
Cost effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
... of patients were receiving antifungal drugs, including voriconazole and caspofungin, prior to diagnosis being confirmed ...of patients with mucormycosis after haematopoietic stem cell transplantation, 29 ... See full document
11
<p>Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis</p>
... of infections named ...infected patients may have other dermatologic symptoms. In the 1960s, amphotericin B deoxycholate was introduced as a second-line therapy for CL and ...regions. ... See full document
8
TREATMENT OF DEEP AND SUPERFICIAL INFECTIONS OF CANDIDA WHAT WE KNOW AND WHAT IS NEW?
... Fluconazole: It is used in oropharyngeal candidiasis, candidemia, and invasive Candidiasis. In Oropharyngeal disease in adults 100 mg/d po/iv for 7-14 days is given. In Candidemia and Invasive Candidiasis ... See full document
7
Comparison of echinocandin antifungals
... of invasive fungal infections, especially those due to Aspergillus ...these infections continues to be ...of infections due Candida spp (such as esophageal candidiasis, invasive ... See full document
10
Histoplasma Antigen Clearance during Treatment of Histoplasmosis in Patients with AIDS Determined by a Quantitative Antigen Enzyme Immunoassay
... 3. Patients treated with amphotericin B experienced most of the drop in antigen during the first 2 weeks of treat- ...addition, patients with the highest baseline antigen levels experienced ... See full document
124
<p>Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis</p>
... Results: In the therapeutic regimen of TAC + glucocorticoids (GC) vs cyclophosphamide (CYC) + GC, the results indicated that the TAC group had high values of CR, TR, albumin, and negative rate of ds-DNA, and low values ... See full document
16
Related subjects